These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2313466)

  • 1. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.
    Martignoni E; Petraglia F; Costa A; Monzani A; Genazzani AR; Nappi G
    J Clin Lab Anal; 1990; 4(1):5-8. PubMed ID: 2313466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.
    Martignoni E; Petraglia F; Costa A; Bono G; Genazzani AR; Nappi G
    Acta Neurol Scand; 1990 May; 81(5):452-6. PubMed ID: 2375247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
    Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
    Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.
    McLean SA; Williams DA; Stein PK; Harris RE; Lyden AK; Whalen G; Park KM; Liberzon I; Sen A; Gracely RH; Baraniuk JN; Clauw DJ
    Neuropsychopharmacology; 2006 Dec; 31(12):2776-82. PubMed ID: 16936702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The concept of stress and the role of hypothalamic and extra-hypothalamic corticotropin-releasing factor (CRF) in the integration of the neuroendocrine and immune responses. Clinical and experimental aspects].
    Puri PL; Palma A; Fabbri A
    Minerva Endocrinol; 1994 Mar; 19(1):19-28. PubMed ID: 8035767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.
    Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I
    Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys.
    Gust DA; Wilson ME; Stocker T; Conrad S; Plotsky PM; Gordon TP
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2556-63. PubMed ID: 10902808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal fluid CRF reduction in Alzheimer's disease.
    Mouradian MM; Farah JM; Mohr E; Fabbrini G; O'Donohue TL; Chase TN
    Neuropeptides; 1986; 8(4):393-400. PubMed ID: 3493444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine changes in Alzheimer's disease.
    Davidson M; Bastiaens L; Davis BM; Shah MB; Davis KL
    Neurol Clin; 1988 Feb; 6(1):149-57. PubMed ID: 2898094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease.
    May C; Rapoport SI; Tomai TP; Chrousos GP; Gold PW
    Neurology; 1987 Mar; 37(3):535-8. PubMed ID: 3029628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.